Among these, CD86 emerged as the most potent independent predictor of in-hospital mortality, regardless of inflammatory status.<h4>Conclusion</h4>This study highlights the importance of CD86-expressing EVs as biomarkers for COVID-19 severity and mortality, suggesting that EV profiling could inform personalized therapies for severe cases. Here, CD86 is linked to COVID-19.